BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37456518)

  • 1. Case report: Vulval sebaceous carcinoma: a report of two cases and literature review focus on treatment and survival.
    Wang X; Wei X
    Pathol Oncol Res; 2023; 29():1611259. PubMed ID: 37456518
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analysis of treatment and prognosis of 59 cases of vulvar melanoma].
    Yuan GW; Li XG; Li N; Yao HW; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2020 Jun; 55(6):395-401. PubMed ID: 32842246
    [No Abstract]   [Full Text] [Related]  

  • 3. Unilateral groin and pelvic irradiation for unilaterally node-positive women with vulval carcinoma.
    Jackson KS; Fankam EF; Das N; Naik R; Lopes AD; Godfrey KA; Hatem MH; Branson AN; Taylor WT
    Int J Gynecol Cancer; 2006; 16(1):283-7. PubMed ID: 16445646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of individualized treatment based on sentinel lymph node biopsy for early-stage vulvar cancer].
    Tu H; Huang H; Gu H; Wan T; Feng Y; Liu J
    Zhonghua Fu Chan Ke Za Zhi; 2015 Aug; 50(8):596-602. PubMed ID: 26675183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sebaceous carcinoma of the vulva treated with sentinel lymph node biopsy: a case report and literature review.
    Yamamoto A; Chigusa Y; Fujimoto M; Yamanoi K; Minamiguchi S; Yasuda E; Hamanishi J; Kondoh E; Mandai M; Yamaguchi K
    Int Cancer Conf J; 2021 Jul; 10(3):239-243. PubMed ID: 34221839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sebaceous carcinoma of the vulva: critical approach to grading and review of the literature.
    Pusiol T; Morichetti D; Zorzi MG
    Pathologica; 2011 Jun; 103(3):64-7. PubMed ID: 22007567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vulvar field resection based on ontogenetic cancer field theory for surgical treatment of vulvar carcinoma: a single-centre, single-group, prospective trial.
    Höckel M; Trott S; Dornhöfer N; Horn LC; Hentschel B; Wolf B
    Lancet Oncol; 2018 Apr; 19(4):537-548. PubMed ID: 29530664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of an individualized surgical therapy of vulvar carcinoma from 1973-1993].
    Köhler U; Schöne M; Pawlowitsch T
    Zentralbl Gynakol; 1997; 119 Suppl 1():8-16. PubMed ID: 9245126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy.
    Burke TW; Levenback C; Coleman RL; Morris M; Silva EG; Gershenson DM
    Gynecol Oncol; 1995 May; 57(2):215-20. PubMed ID: 7729737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients.
    Burger MP; Hollema H; Emanuels AG; Krans M; Pras E; Bouma J
    Gynecol Oncol; 1995 Jun; 57(3):327-34. PubMed ID: 7774836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma.
    Nooij LS; Ongkiehong PJ; van Zwet EW; Bosse T; Creutzberg CL; Gaarenstroom KN; van Poelgeest MI
    Gynecol Oncol; 2015 Dec; 139(3):458-64. PubMed ID: 26432039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery of the vulva in vulvar cancer.
    Micheletti L; Preti M
    Best Pract Res Clin Obstet Gynaecol; 2014 Oct; 28(7):1074-87. PubMed ID: 25132277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic and survival analysis of patients with adenoid cystic carcinoma of vulva: single-institution experience.
    Zhu J; Yin L; Wang Q; Wu X; Ke G
    Int J Clin Oncol; 2020 Dec; 25(12):2144-2150. PubMed ID: 32779039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midline involvement as a risk factor for vulvar cancer recurrence.
    Stankevica J; Macuks R; Baidekalna I; Donina S
    Asian Pac J Cancer Prev; 2012; 13(10):5237-40. PubMed ID: 23244142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative management of vulvar cancer.
    Lukovic J; Han K
    Int J Gynecol Cancer; 2022 Mar; 32(3):338-343. PubMed ID: 35256421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic variables in the treatment of squamous cell carcinoma of the vulva.
    Shimm DS; Fuller AF; Orlow EL; Dosoretz DE; Aristizabal SA
    Gynecol Oncol; 1986 Jul; 24(3):343-58. PubMed ID: 3721307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva.
    Lataifeh I; Nascimento MC; Nicklin JL; Perrin LC; Crandon AJ; Obermair A
    Gynecol Oncol; 2004 Dec; 95(3):701-5. PubMed ID: 15581985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No. 370-Management of Squamous Cell Cancer of the Vulva.
    Francis JA; Eiriksson L; Dean E; Sebastianelli A; Bahoric B; Salvador S
    J Obstet Gynaecol Can; 2019 Jan; 41(1):89-101. PubMed ID: 30580832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dilemmas in the management of patients with vulval epithelioid sarcoma: a literature review.
    Iavazzo C; Gkegkes ID; Vrachnis N
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():1-4. PubMed ID: 24636595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy based on anatomical landmarks and locoregional mapping of inguinofemoral sentinel lymph nodes in women with vulval cancer: an operative technique.
    Kwong FL; Scerif M; Yap JK
    J Obstet Gynaecol; 2023 Dec; 43(1):2207205. PubMed ID: 37170959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.